At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BJDX Bluejay Diagnostics Inc
Trading 08-14 11:03:41 EDT
1.04
-0.02
-1.90%
High1.09
Low1.03
Vol65.00K
Open1.08
D1 Closing1.06
Amplitude5.66%
Mkt Cap4.65M
Tradable Cap4.48M
Total Shares4.47M
T/O68.32K
T/O Rate1.51%
Tradable Shares4.31M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Bluejay Advances Symphony Platform, Strengthens Cash Position
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.